Pharmacokinetics and pharmacodynamics of remifentanil: An update in the year 2000

Current Opinion in Anaesthesiology

Volumn 13, Issue 4, 2000, Pages 449-455

  Egan, Talmage D ^a  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALFENTANIL; DESFLURANE; MIDAZOLAM; MUSCLE RELAXANT AGENT; NITROUS OXIDE; PROPOFOL; REMIFENTANIL; SEVOFLURANE;

ANESTHESIA; ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG INDICATION; DRUG MARKETING; DRUG METABOLISM; DRUG POTENCY; DRUG SAFETY; EYE SURGERY; FEMALE; HUMAN; MALE; NEUROSURGERY; OBSTETRIC CARE; PATIENT CARE; PEDIATRIC SURGERY; PHARMACODYNAMICS; PRIORITY JOURNAL;

EID: 0033869361     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001503-200008000-00009     Document Type: Article

References (72)

1. Remifentanil approved for anesthesia use [news]
2. The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers
3. Remifentanil versus alfentanil: Comparative pharmacokinetics and pharmacodynamies in healthy adult male volunteers
4. Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: Remifentanil (GI87084B)
5. Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development
6. Design, synthesis, and pharmacological evaluation of ultrashort- to long-acting opioid analgesics
7. Opioid receptor activity of GI 87084B, a novel ultra-short acting analgesic, in isolated tissues
8. Naloxone-induced and spontaneous reversal of depressed ventilatory responses to hypoxia during and after continuous infusion of remifentanil or alfentanil
9. Histamine concentrations and hemodynamic responses after remifentanil
10. Reduction of isoflurane minimal alveolar concentration by remifentanil
11. Pharmacokinetics and pharmacodynamics of remifentanil in persons with renal failure compared with healthy volunteers
12. Pharmacokinetics and pharmacodynamics of remifentanil in volunteer subjects with severe liver disease
13. Remifentanil pharmacokinetics in obese versus lean patients
14. Does size matter?
15. Influence of arteriovenous sampling on remifentanil pharmacokinetics and pharmacodynamics
16. Determination of the potency of remifentanil compared with alfentanil using ventilatory depression as the measure of opioid effect
17. Behavioral and physiological effects of remifentanil and alfentanil in healthy volunteers
18. Comparative pharmacokinetics and pharmacodynamics of remifentanil, its principle metabolite (GR90291) and alfentanil in dogs
19. The comparative pharmacodynamics of remifentanil and its metabolite, GR90291, in a rat electroencephalographic model
20. Enzymatic and chemical hydrolysis of remifentanil
21. In vitro metabolism of remifentanil: The effects of pseudocholinesterase deficiency
22. Remifentanil's effect is not prolonged in a patient with pseudocholinesterase deficiency
23. Remifentanil administration during monitored anesthesia care: Are intermittent boluses an effective alternative to a continuous infusion?
24. Is an infusion pump necessary to safely administer remifentanil?
25. Reducing the demand for admission to intensive care after major abdominal surgery by a change in anaesthetic practice and the use of remifentanil
26. Remifentanil as an adjuvant during desflurance anesthesia facilitates early recovery after ambulatory surgery
27. Remifentanil infusion facilitates early recovery for obese outpatients undergoing laparoscopic cholecystectomy
28. Surrogate end points. Are they meaningful?
29. Cost analysis of remifentanil and fentanyl for neurosurgical anesthesia
30. Effects of remifentanil, a new short-acting opioid, on cerebral blood flow, brain electrical activity, and intracranial pressure in dogs anesthetized with isoflurane and nitrous oxide
31. Intracranial pressure and hemodynamic effects of remifentanil versus alfentanil in patients undergoing supratentorial craniotomy
32. Comparison of remifentanil and fentanyl in patients undergoing craniotomy for supratentorial space-occupying lesions
33. Propofol anesthesia for craniotomy: A double-blind comparison of remifentanil, alfentanil, and fentanyl
34. The use of a remifentanil infusion for hemodynamic control during intracranial surgery
35. Rate of CSF formation and resistance to reabsorption of CSF during sevoflurane or remifentanil in rabbits
36. Remifentanil and propofol combination for awake craniotomy: Case report with pharmacokinetic simulations
37. Target-controlled infusion of propofol and remifentanil combined with bispectral index monitoring for awake craniotomy
38. The use of remifentanil infusion to allow intraoperative awakening for intentional fracturing of the anterior cervical spine
39. Safety and feasibility of continuous infusion of remifentanil in the neurosurgical intensive care unit
40. Intravenous remifentanil: Placental transfer, maternal and neonatal effects
41. The use of remifentanil in general anaesthesia for caesarean section in a patient with mitral valve disease
42. The use of remifentanil for cesarean section in a parturient with recurrent aortic coarctation
43. Remifentanil in emergency caesarean section in pre-eclampsia complicated by thrombocytopenia and abnormal liver function
44. General anesthesia with remifentanil for cesarean section in a parturient with an acoustic neuroma
45. Patient controlled analgesia using remifentanil in the parturient with thrombocytopaenia
46. The use of remifentanil infusion to facilitate epidural catheter placement in a parturient: A case report with pharmacokinetic simulations
47. A randomized multicenter study of remifentanil compared with alfentanil, isoflurane, or propofol in anesthetized pediatric patients undergoing elective strabismus surgery
48. Remifentanil pharmacokinetics in neonates
49. Quality of emergence from anesthesia and incidence of vomiting with remifentanil in a pediatric population
50. The effects of cardiopulmonary bypass on remifentanil kinetics in children undergoing atrial septal defect repair
51. A randomized, double-blinded study of remifentanil versus fentanyl for tonsillectomy and adenoidectomy surgery in pediatric ambulatory surgical patients
52. Conscious sedation with remifentanil and midazolam during brief painful procedures in children
53. Remifentanil and propofol for sedation in children and young adolescents undergoing diagnostic flexible bronchoscopy
54. Trabecular outflow facility and formation rate of aqueous humor during anesthesia with sevoflurane-nitrous oxide or sevoflurane-remifentanil in rabbits
55. Remifentanil prevents an increase in intraocular pressure after succinylcholine and tracheal intubation
56. Remifentanil versus alfentanil as analgesic adjuncts during placement of ophthalmologic nerve blocks
57. Remifentanil, propofol or both for conscious sedation during eye surgery under regional anaesthesia
58. Remifentanil-based anesthesia versus a propofol technique for otologic surgical procedures
59. Transition to post-operative epidural or patient-controlled intravenous analgesia following total intravenous anaesthesia with remifentanil and propofol for abdominal surgery
60. A multicenter evaluation of remifentanil for early postoperative analgesia
61. Postoperative pain control following remifentanil-based anaesthesia for major abdominal surgery
62. Lack of rapid development of opioid tolerance during alfentanil and remifentanil infusions for postoperative pain
63. Postoperative pain management and recovery after remifentanil-based anaesthesia with isoflurane or propofol for major abdominal surgery. Remifentanil Study Group
64. The efficacy of intravenous 0.15 versus 0.25 mg/kg intraoperative morphine for immediate postoperative analgesia after remifentanil-based anesthesia for major surgery
65. Bolus dose remifentanil for control of haemodynamic response to tracheal intubation during rapid sequence induction of anaesthesia
66. Comparison of different doses of remifentanil on the cardiovascular response to laryngoscopy and tracheal intubation
67. Effect of a remifentanil bolus dose on the cardiovascular response to emergence from anaesthesia and tracheal extubation
68. Comparison of remifentanil with alfentanil or suxamethonium following propofol anaesthesia for tracheal intubation
69. Dosing study of remifentanil and propofol for tracheal intubation without the use of muscle relaxants
70. Tracheal intubation without the use of muscle relaxants: Remifentanil or alfentanil in combination with propofol
71. Total intravenous anesthesia with remifentanil and propofol for implantation of cardioverter-defibrillators in patients with severely reduced left ventricular function
72. Remifentanil for conscious sedation and analgesia during awake fiberoptic tracheal intubation: A case report with pharmacokinetic simulations